GcMAF
Supports immune system efficiency and recovery.
$705
A macrophage-activating factor studied for supporting immune cell efficiency and coordination in research settings.
- Explored for enhancing macrophage activity and immune surveillance.
- Investigated in chronic-condition and immune-recovery research contexts.
- Studied for general immune-system support alongside standard care.
1
Dosing schedule
Concentration
12000ng/3ml
Frequency
Daily
Dose
10
Duration
1 Month
Break
1 Month
GcMAF supports immune modulation and is studied in chronic-condition and oncology-adjacent research contexts. Research use only. Not a substitute for medical treatment or diagnosis.
For research use only. Not for human consumption. Not evaluated by the FDA.